“…Most current clinical approaches with cadaveric islets rely on infusion into the liver, rendering them irretrievable [3][4][5][6]. Other transplantation sites used in research, such as the kidney capsule [7,8,11] or fat pad [12], are not viable for clinical transplantation. Large spaces, such as subcutaneous [13,14], intraperitoneal (IP) [9,15], or in the omentum [16], can potentially hold a sufficiently large cellembedded device to convey a positive clinical outcome while also allowing for cell retrieval.…”